Drug intelligence / Profile preview

hyaluronic acid + galacto-xyloglucan

Development stage
Unknown
Lead developer
ESTEVE Pharmaceuticals
Administration
Ophthalmic
01

Overview

Hyaluronic acid + galacto-xyloglucan is a topical ophthalmic combination therapy used as a multiple-action tear substitute for the management of dry eye disease (DED). The formulation typically consists of 0.4% hyaluronic acid, a high-molecular-weight glycosaminoglycan with exceptional water-retention and mucoadhesive properties, and 0.2% galacto-xyloglucan (also known as tamarind seed polysaccharide), a natural polysaccharide that provides a protective barrier and promotes corneal wound healing. These two polymers act synergistically to stabilize the tear film, reduce ocular surface evaporation, and provide long-lasting lubrication. Clinical studies have demonstrated its efficacy in improving subjective symptoms and objective signs of DED, including tear film breakup time and corneal staining, particularly in patients with meibomian gland dysfunction or those using medications like oral contraceptives or isotretinoin.

Brand names
Xiloial ZeroXiloialRohto Dry Eye Relief
Other names
HA-GXhyaluronic acid + tamarind seed polysaccharideHA + TS-polysaccharideHA + TSP
02

Targets

MUC (Mucin family)

Beyond the preview

Go deeper on hyaluronic acid + galacto-xyloglucan.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on hyaluronic acid + galacto-xyloglucan.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call